PROGNOSTIC-SIGNIFICANCE OF HER-2-NEU EXPRESSION IN BREAST-CANCER AND ITS RELATIONSHIP TO OTHER PROGNOSTIC FACTORS

被引:256
作者
RILKE, F
COLNAGHI, MI
CASCINELLI, N
ANDREOLA, S
BALDINI, MT
BUFALINO, R
DELLAPORTA, G
MENARD, S
PIEROTTI, MA
TESTORI, A
机构
[1] IST NAZL STUDIO & CURA TUMORI,DIV EXPTL ONCOL E,I-20133 MILAN,ITALY
[2] IST NAZL STUDIO & CURA TUMORI,DIV SURG ONCOL B,I-20133 MILAN,ITALY
[3] IST NAZL STUDIO & CURA TUMORI,DIV EXPTL ONCOL A,I-20133 MILAN,ITALY
[4] IST NAZL STUDIO & CURA TUMORI,PRESTCO,INFORMAT LAB,I-20133 MILAN,ITALY
关键词
D O I
10.1002/ijc.2910490109
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Archival surgical specimens from 1,210 female breast cancer patients treated between 1968 and 1971 and with a 19-year follow-up were reanalyzed with special reference to several parameters, such as size of the primary tumor, axillary nodel involvement, histologic grade, degree of inflammatory infiltrate (LPI) of the tumor and expression of the neu onco-protein (p185) as detected by immunohistochemistry. In a multifactorial analysis the 4 former factors were found to be independent progrnostic parameters. Over-expression of p185 was found to be related to tumor size and grade and to LPI but not to pathologic nodal status. Over-expression of p185 showed a negative impact upon survival in node-positive but not in node-negative patients. However, in the subset of node-negative patients without LP1, p185 over-expression showed the same correlation with a poor prognosis as in node-positive patients. In contrast, in node-negative and LPI-positive good prognosis. Also, the prognosis of patients with positive nodes, presence of LPI and no p185 over-expression was similar to that of patients with negative nodes, absence of LPI and p185 over-expression.
引用
收藏
页码:44 / 49
页数:6
相关论文
共 30 条
[1]   RELATIVE SIGNIFICANCE OF PROGNOSTIC FACTORS IN BREAST CARCINOMA [J].
ALDERSON, MR ;
STAUNTON, MD ;
HAMLIN, I .
BRITISH JOURNAL OF CANCER, 1971, 25 (04) :646-+
[2]   ONCOGENIC ACTIVATION OF THE NEU-ENCODED RECEPTOR PROTEIN BY POINT MUTATION AND DELETION [J].
BARGMANN, CI ;
WEINBERG, RA .
EMBO JOURNAL, 1988, 7 (07) :2043-2052
[3]   AN IMMUNOHISTOCHEMICAL EVALUATION OF C-ERB-2 EXPRESSION IN HUMAN-BREAST CARCINOMA [J].
BARNES, DM ;
LAMMIE, GA ;
MILLIS, RR ;
GULLICK, WL ;
ALLEN, DS ;
ALTMAN, DG .
BRITISH JOURNAL OF CANCER, 1988, 58 (04) :448-452
[4]  
BERCHUCK A, 1990, CANCER RES, V50, P4087
[5]  
BERG JW, 1971, CANCER, V28, P1453, DOI 10.1002/1097-0142(197112)28:6<1453::AID-CNCR2820280618>3.0.CO
[6]  
2-P
[7]   PROGNOSIS IN BREAST-CANCER UTILIZING HISTOLOGIC CHARACTERISTICS OF PRIMARY TUMOR [J].
BLACK, MM ;
BARCLAY, THC ;
HANKEY, BF .
CANCER, 1975, 36 (06) :2048-2055
[8]   HISTOLOGICAL GRADING AND PROGNOSIS IN BREAST CANCER - A STUDY OF 1409 CASES OF WHICH 359 HAVE BEEN FOLLOWED FOR 15 YEARS [J].
BLOOM, HJG ;
RICHARDSON, WW .
BRITISH JOURNAL OF CANCER, 1957, 11 (03) :359-&
[9]   HISTOLOGY IN BREAST-CANCER PROGNOSIS [J].
CHAMPION, HR ;
WALLACE, IWJ ;
PRESCOTT, RJ .
BRITISH JOURNAL OF CANCER, 1972, 26 (02) :129-&
[10]   THE SUBCELLULAR-LOCALIZATION OF THE NEU PROTEIN IN HUMAN NORMAL AND NEOPLASTIC-CELLS [J].
DEPOTTER, CR ;
QUATACKER, J ;
MAERTENS, G ;
VANDAELE, S ;
PAUWELS, C ;
VERHOFSTEDE, C ;
EECHAUTE, W ;
ROELS, H .
INTERNATIONAL JOURNAL OF CANCER, 1989, 44 (06) :969-974